Drug Profile
TV 141
Latest Information Update: 23 Feb 2004
Price :
$50
*
At a glance
- Originator Teva Pharmaceutical Industries
- Class Antiepileptic drugs
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 23 Feb 2004 Discontinued - Phase-I for Epilepsy in France (unspecified route)
- 26 Jun 1998 Phase-I clinical trials for Epilepsy in France (Unknown route)